Warning: Undefined variable $zfal in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Deprecated: str_replace(): Passing null to parameter #3 ($subject) of type array|string is deprecated in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 530
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 531
 
English Wikipedia
Nephropedia Template TP (
Twit Text
DeepDyve
Pubget Overpricing |  
lüll
The use of PTH in the treatment of osteoporosis Borba VZ; Manas NCArq Bras Endocrinol Metabol 2010[Mar]; 54 (2): 213-9Anabolic drugs have recently widened therapeutic options in osteoporosis treatment, as they influence processes associated with bone formation to a greater extent and earlier than bone reabsortion. They positively affect a number of skeletal properties besides bone density, as intermittent administration of parathyroid hormone (PTH) results in an increase in the number and activity of osteoblasts leading to an increase in bone mass and improvement in skeletal architecture at both the trabecular and cortical bone. Human recombinant parathyroid hormone (hrPTH 1-84) and human recombinant PTH peptide 1-34 (teriparatide) belong to this group. The objective of this paper is to review PTH actions, benefits and adverse effects, action on biochemical markers, combination therapy with antiresorptive agents, impact of antiresorptive therapy prior to anabolic treatment, sequential treatment, and effect on glucocorticoid-induced osteoporosis.|Anabolic Agents/adverse effects/*therapeutic use[MESH]|Biomarkers/metabolism[MESH]|Bone Density Conservation Agents/adverse effects/*therapeutic use[MESH]|Bone Density/drug effects[MESH]|Bone Resorption/metabolism[MESH]|Humans[MESH]|Lumbar Vertebrae/drug effects[MESH]|Osteoporosis/*drug therapy[MESH]|Parathyroid Hormone/adverse effects/*therapeutic use[MESH]|Spinal Fractures/prevention & control[MESH]|Teriparatide/adverse effects/*therapeutic use[MESH] |
